Atrys Health, S.A. (BME: ATRY)

Market Cap	255.91M
Revenue	211.11M
Net Income	-39.07M
Shares Out	75.94M
EPS	-0.51
PE Ratio	n/a
Forward PE	293.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,748
Open	3.360
Previous Close	3.370
Day's Range	3.160 - 3.370
52-Week Range	2.770 - 4.770
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Atrys Health

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly kno...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,084
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ATRY